Comparison of osteogenic potentials of human rat BMP4 and BMP6 gene therapy using [E1-] and [E1-,E2b-] adenoviral vectors

International Journal of Medical Sciences

Volumn 3, Issue 3, 2006, Pages 97-105

  Li, Hongwei ^a   Jin, Zhong Li ^a   Pittman, Debra D ^b   Amalfitano, Andy ^c   Hankins, Gerald R ^a   Helm, Gregory A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b PFIZER INC   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; COMPLEMENTARY DNA;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ARTICLE; DNA SEQUENCE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE THERAPY; IMMUNE RESPONSE; IMMUNOCOMPETENCE; MOLECULAR CLONING; NONHUMAN; OSTEOBLAST; PROTEIN EXPRESSION; RAT; VIRUS GENE;

EID: 33745811246     PISSN: 14491907     EISSN: 14491907     Source Type: Journal    
DOI: 10.7150/ijms.3.97     Document Type: Article

References (47)

1. Alden TD, Pittman DD, Hankins GR, et al. In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector. Hum Gene Ther 1999;10:2245-53.
2. Amalfitano A, Chamberlain JS. Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapy. Gene Ther 1997; 4:258-63.
3. Amalfitano A, Hauser MA, Hu H, et al. Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted. J Virol 1998; 72:926-33.
4. Aoki H, Fujii M, Imamura T, et al. Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. J Cell Sci 2001; 114:1483-9.
5. Balague C, Zhou J, Dai Y, et al. Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector. Blood 2000; 95: 820-8.
6. Berns KI, Giraud C. Adenovirus and adeno-associated virus as vectors for gene therapy. Ann N Y Acad Sci 1995; 772:95-104.
7. Camargo FD, Huey-Louie DA, Finn AV, et al. Germline incorporation of a replication-defective adenoviral vector in mice does not alter immune responses to adenoviral vectors. Mol Ther 2000; 2:496-504.
8. Carninci P, Shibata Y, Hayatsu N, et al. Normalization and subtraction of cap-trapper-selected cDNAs to prepare full-length cDNA libraries for rapid discovery of new genes. Genome Res 2000; 10:1617-30.
9. Ducy P, Karsenty G. The family of bone morphogenetic proteins. Kidney Int 2000; 57:2207-14.
10. Dumont RJ, Dayoub H, Li JZ, et al. Ex vivo bone morphogenetic protein-9 gene therapy using human mesenchymal stem cells induces spinal fusion in rodents. Neurosurgery 2002; 51:1239-1245.
11. Ebisawa T, Tada K, Kitajima I, Tojo K, Sampath TK, Kawabata M, Miyazono K, Imamura T. Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J Cell Sci 1999; 112:3519-27.
12. Fisher KJ, Choi H, Burda J, et al. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 1996; 217:11-22.
13. Fujii M, Takeda K, Imamura T, Aoki H, et al. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell 1999; 10:3801-13.
14. Gahery-Segard H, Farace F, Godfrin D, et al. Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity. J Virol 1998; 72:2388-97.
15. Gahery-Segard H, Juillard V, Gaston J, et al. Humoral immune response to the capsid components of recombinant adenoviruses: routes of immunization modulate virus-induced Ig subclass shifts. Eur J Immunol 1997; 27:653-9.
16. Gitelman SE, Kobrin M, Lee A, et al. Structure and sequence of the mouse Bmp6 gene. Mamm Genome 1997; 8:212-4.
17. Gitelman SE, Kobrin MS, Ye JQ, et al. Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo. J Cell Biol 1994; 126:1595-609.
18. He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998; 95:2509-14.
19. Helm GA, Alden TD, Sheehan JP, Kallmes D. Bone morphogenetic proteins and bone morphogenetic protein gene therapy in neurological surgery: a review. Neurosurgery 2000; 46:1213-22.
20. Hodges BL, Serra D, Hu H, Begy CA, et al. Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein. J Gene Med 2000; 2:250-9.
21. Jane JAJr, Dunford BA, Kron A, et al. Ectopic osteogenesis using adenoviral bone morphogenetic protein (BMP)-4 and BMP-6 gene transfer. Mol Ther 2002; 6:464-70.
22. Knittel T, Fellmer P, Muller L, Ramadori G. Bone morphogenetic protein-6 is expressed in nonparenchymal liver cells and upregulated by transforming growth factor-beta 1. Exp Cell Res 1997; 232:263-9.
23. Li JZ, Hankins GR, Kao C, et al. Osteogenesis in rats induced by a novel recombinant helper-dependent bone morphogenetic protein-9 (BMP-9) adenovirus. J Gene Med 2003; 5:748-56.
24. Li JZ, Holman D, Li H, et al. Long-term tracing of adenoviral expression in rat and rabbit using luciferase imaging. J Gene Med 2005;7(6):792-802
25. Li JZ, Li H, Sasaki T, et al. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Gene Ther 2003; 10:1735-43.
26. Lin RH, Mamula MJ, Hardin JA, Janeway CAJr. Induction of autoreactive B cells allows priming of autoreactive T cells. J Exp Med 1991; 173:1433-9.
27. Liu Q, Muruve DA. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther 2003; 10:935-40.
28. Lyons K, Graycar JL, Lee A, et al. Vgr-1, a mammalian gene related to Xenopus Vg-1, is a member of the transforming growth factor beta gene superfamily. Proc Natl Acad Sci U S A 1989; 86:4554-8.
29. Mamula MJ, Lin RH, Janeway CAJr, Hardin JA. Breaking T cell tolerance with foreign and self co-immunogens. A study of autoimmune B and T cell epitopes of cytochrome c. J Immunol 1992; 149:789-95.
30. Miller AF, Harvey SA, Thies RS, Olson MS. Bone morphogenetic protein-9. An autocrine/paracrine cytokine in the liver. J Biol Chem 2000; 275:17937-45.
31. Miyazono K, Kusanagi K, Inoue H. Divergence and convergence of TGF-beta/BMP signaling. J Cell Physiol 2001; 187:265-76.
32. Molinier-Frenkel V, Lengagne R, et al. Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response. J Virol 2002; 76:127-35.
33. Morral N, O'Neal W, Rice K, Leland M, et al. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc Natl Acad Sci U S A 1999; 96:12816-21.
34. Morsy MA, Gu M, Motzel S, et al. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc Natl Acad Sci U S A 1998; 95:7866-71.
35. Musgrave DS, Bosch P, Ghivizzani S, et al. Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone 1999; 24:541-7.
36. Nohe A, Keating E, Knaus P, Petersen NO. Signal transduction of bone morphogenetic protein receptors. Cell Signal 2004; 16:291-9.
37. Ohashi PS, Oehen S, Buerki K, et al. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991; 65:305-17.
38. Okubo Y, Bessho K, Fujimura K, et al. The time course study of osteoinduction by bone morphogenetic protein-2 via adenoviral vector. Life Sci 2001; 70:325-36.
39. Sauermann U, Meyermann R, Schluesener HJ. Cloning of a novel TGF-beta related cytokine, the vgr, from rat brain: cloning of and comparison to homologous human cytokines. J Neurosci Res 1992; 33:142-7.
40. Song JJ, Celeste AJ, Kong FM, et al. Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology 1995; 136:4293-7.
41. Tripathy SK, Black HB, Goldwasser E, Leiden JM. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med 1996; 2:545-50.
42. van Ginkel FW, McGhee JR, Liu C, et al. Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene. J Immunol 1997; 159:685-93.
43. Varady P, Li JZ, Cunningham M, et al. Morphologic analysis of BMP-9 gene therapy-induced osteogenesis. Hum Gene Ther 2001; 12:697-710.
44. von Bubnoff A, Cho KW. Intracellular BMP signaling regulation in vertebrates: pathway or network? Dev Biol 2001; 239:1-14
45. Von Seggern DJ, Chiu CY, Fleck SK, et al. A helper-independent adenovirus vector with E1, E3, and fiber deleted: structure and infectivity of fiberless particles. J Virol 1999; 73:1601-8
46. Wozney JM. Bone morphogenetic proteins. Prog Growth Factor Res 1989; 1:267-80
47. Zinkernagel RM, Cooper S, Chambers J, et al. Virus-induced autoantibody response to a transgenic viral antigen. Nature 1990; 345:68-71